Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran

Idarucizumab (Praxbind) is a humanized antibody fragment, that reversibly and with high affinityties up dabigatran (Pradaxa). Anticoagulation reversal is achieved immediately, and with no procoagulant effect. It is administered intravenously and clearance is renal. The main clinical application of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannandrea, David, Mengoni, Anna, Carluccio, Erberto, Ambrosio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536811/
https://www.ncbi.nlm.nih.gov/pubmed/31213821
http://dx.doi.org/10.2147/VHRM.S181806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536811/
https://www.ncbi.nlm.nih.gov/pubmed/31213821
http://dx.doi.org/10.2147/VHRM.S181806

Ejemplares similares